This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in ...

With legendary CEO Warren Buffett's time complete with Berkshire Hathaway, many investors are wondering where the company ...

In fiscal Q3 (the period ended Oct. 26, 2025), the chipmaker saw its quarterly revenue hit $57.0 billion, up 62% year over ...

After underperforming in 2025, now may be the time to buy shares of this leading rural retailer.

The energy industry is in a transitional period. While fossil fuels are crucial to the economy these days, lower-carbon ...

The good news is that even average investors who aren't paid to pick stocks can still beat the market. To help you achieve ...

After three fantastic years of market gains, many investors are wondering if the rally will come to an end in 2026.

Here are three stocks -- including a turnaround, a growth story, and a high-yield play -- that investors will want to dig ...

In addition to a pull-forward in demand in Q3, the company benefited from delivering more vehicles than it produced in the ...

Zooming out, $10 million (or therabouts) isn't a large figure when compared to Ondas's total revenue, which approached $7.2 ...

Join us as we dissect Texas Roadhouse's stock potential and uncover whether this beloved steakhouse chain can continue to ...

A competitor's setback was Xeris Biopharma 's ( XERS +7.39%) gain on Hump Day. On news that a potential commercial threat to ...